Broad spectrum carbapenem
Imipenem/Cilastatin Kabi is an intravenous broad spectrum beta-lactam antibiotic of the carbapenem class. Its bactericidal activity is against a broad spectrum of Gram-positive and Gram-negative bacteria, includin anaerobic pathogens.
Imipenem/Cilastatin Kabi is a combination of the antibiotic acting drug imipenem and the dehydropeptidase inhibitor cilastatin, which inhibits the imipenem degradation by the human enzyme dehydropeptidase. Cilastatin does not have own antibiotic activity.
Imipenem/Cilastatin Kabi is indicated for the treatment of the following infections in adults and children 1 year of age and above:
• Intra-abdominal infections
• Lower respiratory tract infections
• Gynecological infections
• Urinary tract infections
• Skin and soft-tissue infections
Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Imipenem/Cilastatin Kabi is not indicated for the treatment of meningitis.
| Strengths | Packaging | Pack size |
|---|---|---|
| 250 mg/250 mg | 20 ml uncoloured glass vial | 10 |
| 500 mg/500 mg | 20 ml uncoloured glass vial | 10 |
* Not all pack sizes may be marketed or available locally.
* Product images are for illustration purposes only.
Please note that this product may not be available in all countries due to different registration status. Additionally, approved indications, contraindications, side effects, warnings and all other product characteristics may differ between countries.
If you require any information, please contact your local organization.
